Search clinical trials for: survival Risk

Total 17365 results

jingxue

Recruiting

Lipoprotein a is an Independent Risk Factor for Overall Survival in Patients With Pancreatic Cancer: a Propensity Score Matching Analysis

Pancreatic Carcinoma; Lipoprotein a; Overall Survival; Prognosis

China
Zhujiang Hospital

Recruiting

AI Based Multi-modal Parameter of Peripheral Blood Cells (MMPBC) Predicts Survival Risk in Critically Ill Children

Children

China
Comprehensive Cancer Centre The Netherlands

Recruiting

High-Risk prostatE Cancer radiatiOn Versus surgERy (RECOVER)

Prostate Cancer | Prostate Adenocarcinoma

Netherlands
Lebanese University
Hospital Saydet Zgharta University Medical Center

Recruiting

LUSZ Treatment Efficacy in Hospitalized COVID-19 Patients (LUSZ_AVIST)

COVID-19 | Hospitalized COVID-19 Patients

Lebanon
Claus Cursiefen
German Federal Ministry of Education and Research; Uniklinik Köln, Zentrum... and other collaborators

Recruiting

Pretreatment to Promote Graft Survival After Subsequent High-risk Corneal Transplantation [CrossCornealVision]

Corneal Transplantation

Germany
Amsterdam UMC, location VUmc
Dutch Cancer Society

Recruiting

Single-dose Preoperative Partial Breast Irradiation in Low-risk Breast Cancer Patients (ABLATIVE-2)

Breast Cancer

Netherlands
Fudan University

Recruiting

R-CDOP Combined With Intrathecal Methotrexate for DLBCL Patients With High-risk of CNS Relapse

Diffuse Large B-cell Lymphoma

China
Instituto de investigación e innovación biomédica...

Recruiting

Survival Analysis After Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer and Risk Factors

Pancreatic Adenocarcinoma | Pancreatic Cancer Resectable

Spain
Grupo Argentino de Tratamiento de la Leucemia Aguda

Recruiting

RWE of Pediatric-like Protocol for AYA Patients With Ph-negative ALL

Acute Lymphoblastic Leukemia, Adult

Argentina
Fudan University

Recruiting

Thymosin-alpha 1 for Adjuvant Treatment After Radical Resection of High-risk Stage II and III Colorectal Cancer

Stage III Colorectal Cancer | Stage II Colorectal Cancer

China
The Central and Eastern European Gynecologic Oncology...

Recruiting

Intermediate Risk Cervical Cancer: Radical Surgery +/- Adjuvant Radiotherapy (CERVANTES)

Cervical Cancer

Czechia
Hoffmann-La Roche

Recruiting

A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy (Astefania)

Breast Cancer

Korea, Republic of, United States, Australia, China, Ukraine, Spain, United Kingdom, Turkey, Mexico, Brazil, Austria, Belgium, Denmark, Germany, Greece, Russian Federation, Taiwan, France, Kenya, New Zealand, Portugal, Thailand, Rom... and more
NRG Oncology
National Cancer Institute (NCI)

Recruiting

Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

Prostate Adenocarcinoma | Metastatic Malignant Neoplasm in the Bone | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8

United States, Canada
Emory University
PeachBowl LegACy Fund

Recruiting

Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors (AflacST1903)

Solid Tumor

United States
Seoul National University Hospital

Not yet recruiting

3 Year Recurrence Free Survival in Ultra-low-risk Endometrial Cancer (TREE PRO)

Endometrial Cancer
National Cancer Institute (NCI)

Recruiting

Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer

Prostate Cancer

United States
Peking University First Hospital
Peking University People's Hospital; The Second Hospital of Hebei Medical University and other collaborators

Recruiting

A Multi-center Prospective Cohort Study Based on Peritoneal Dialysis Telemedicine-assisted Platform (PDTAP)

Peritoneal Dialysis

China
Peking University People's Hospital

Recruiting

RIC Regimen for Low- and Intermediate-risk MDS Receiving Haplo-HSCT

Myelodysplastic Syndromes

China
Uppsala University

Recruiting

A Randomized Trial to Assess the Role of Imaging During Follow up After Radical Surgery of High Risk Melanoma (TRIM)

Malignant Melanoma

Sweden
Peking University People's Hospital
Xijing Hospital; Beijing Friendship Hospital; Peking Union Medical College Hospital and other collaborators

Recruiting

Effect of Concurrent Capecitabine-based Long-term Radiotherapy Followed by XELOX Plus TME in Patients With High Risk Rectal Cancer: a Multi-centers, Randomized Controlled, Open-Label Trial (EXPLORE)

Rectal Cancer | Pathological Complete Response | Disease Free Survival

China
Lawson Health Research Institute

Recruiting

Validation of the Risk Stratification Score in Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

Canada, Italy
National Cancer Institute (NCI)

Active, not recruiting

Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery

Stage IV Cutaneous Melanoma AJCC v6 and v7 | Recurrent Melanoma | Stage IIIC Cutaneous Melanoma AJCC v7 | Melanoma of Unknown Primary | Stage IIIB Cutaneous Melanoma AJCC v7

United States, Canada
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group; Cancer and Leukemia Group B; North Central...

Active, not recruiting

Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer

Breast Adenocarcinoma

United States, Peru, South Africa
National Cancer Institute (NCI)

Active, not recruiting

Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia

Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Myelodysplastic Syndrome With Excess Blasts | Chronic Myelomonocytic Leukemia-1 | Chronic Myelomonocytic Leukemia-2 | Myelodysplastic Syndrome With Excess Blasts-1 | Myelodysplastic Syndrome/Acute Myeloid Leukemia

Canada, United States
Jinling Hospital, China

Completed

Risk Factors of Postoperative Complications and Survival Rate in Pancreatic Ductal Adenocarcinoma Patients

Pancreatic Cancer

China
Fujian Medical University
Fujian Medical University Union Hospital

Completed

Systemic Oxidative Stress Score as a Predictor of Gastric Cancer Survival and Recurrence Risk

Gastric Cancer

China
Fujian Medical University
Fujian Medical University Union Hospital

Completed

A Novel Online Calculator to Predict Long-term Survival and Recurrence Risk of Patients With Gastric Adenocarcinoma

Gastric Cancer

China
Fox Chase Cancer Center

Active, not recruiting

Perioperative Risk Study (PRS)

Surgery | Tumors | Primary Neoplasm | Secondary Neoplasm

United States
University of Göttingen

Completed

Retrospective Database Study: Survival of Direct Composite Restorations Placed Under General Anesthesia in Adult Patients With Intellectual and/or Physical Disabilities and Risk Factors for Repeated Dental Treatment in General Anesthesia

Intellectual and/or Physical Disabilities | Dental Treatment Under General Anesthesia
Centre Leon Berard

Completed

Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (ImadGist)

Gastrointestinal Stromal Tumors | Resected Gastrointestinal Stromal Tumors | Non-metastatic | High Risk of Recurrence | KIT Gene Mutation

France
Radboud University Medical Center

Completed

Risk Assessment Tool for Graft Survival in Pediatric Kidney Transplantation

Pediatric Kidney Disease | Kidney Transplant Failure and Rejection
Radboud University Medical Center

Completed

Incidence, Risk Factor, Treatment and Overall Survival of Locally Recurrent Rectal Cancer

Rectal Neoplasms | Neoplasm Recurrence, Local
Chang Gung Memorial Hospital

Completed

Optimized Peak VO2 in Predicting Advanced HF

Heart Failure | Transplant; Failure, Heart | Morality

Taiwan
University of Arkansas

Active, not recruiting

Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy

Myeloma

United States
Maastricht University Medical Center

Active, not recruiting

Time to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell Carcinoma

Recurrence | Carcinoma, Squamous Cell | Skin Cancer | Metastasis | Carcinoma, Squamous Cell of Head and Neck | Carcinoma, Squamous Cell, Skin

Netherlands
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Terminated

Afatinib After Chemoradiation and Surgery in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck at High-Risk of Recurrence

Head and Neck Squamous Cell Carcinoma

United States
Peking University International Hospital
Peking University First Hospital; Beijing Friendship Hospital; Shanghai Zhongshan... and other collaborators

Enrolling by invitation

Neoadjuvant Chemotherapy Combined With Targeted Treatment in High-risk Retroperitoneal Sarcoma (NATARS)

Retroperitoneal Sarcoma

China
Spanish Breast Cancer Research Group
Sanofi

Completed

Docetaxel, Doxorubicin (A), Cyclophosphamide (C) (TAC) vs 5-Fluorouracil, A, C (5FAC) Breast Cancer Adjuvant Treatment

Breast Neoplasms

Spain
Paris Translational Research Center for Organ Transplantation

Completed

Human Versus Computer-based Predictions of Long Allograft Survival (iBox vs Human)

Kidney Transplant Failure

France
CareDx

Withdrawn

KidneyCare Immuno-optimization in Renal Allografts (KIRA)

Immunosuppression | Kidney Transplant | Allograft
Maastricht Radiation Oncology
The Netherlands Cancer Institute; Diakonessenhuis, Utrecht

Completed

Radiotherapy After Primary Chemotherapy for Breastcancer (RAPCHEM)

Breast Cancer

Netherlands
Radboud University Medical Center

Completed

Incidence, Risk Factor, Treatment and Overall Survival of Locoregionally Recurrent Colon Cancer

Colonic Neoplasms | Neoplasm Recurrence, Local
CR-CSSS Champlain-Charles-Le Moyne

Completed

HDR Brachytherapy as Monotherapy for Low and Intermediate Risk Prostate Cancer (BRP2)

Prostate Cancer

Canada
Zonguldak Bulent Ecevit University

Completed

Effect of Blood Group on the Survival Status of Intensive Care Patients

Critical Illness | Nurse's Role | Prognosis | Risk Factor

Turkey
Shanghai 10th People's Hospital

Completed

Ankle Brachial Index Combined With Serum Uric Acid Levels Improve Prediction All Cause Mortality and Cardiovascular Mortality in the Elderly Chinese Population (abilities)

Ankle Brachial Index
University Hospital, Basel, Switzerland

Completed

COVID-19 Survival - The COVIVA Study (COVIVA)

COVID-19 | SARS-CoV 2

Switzerland
M.D. Anderson Cancer Center
Novartis

Completed

Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC)

Kidney Cancer

United States
Medical College of Wisconsin

Completed

Effect of Presenting Survival Information as Text or Pictograph During Periviable Birth Counseling

Premature Birth

United States
Bayer

Completed

Study Performed at Various Medical Centers to Learn More About Survival and Expected Course of Pulmonary Arterial Hypertension, a Type of High Blood Pressure in the Lungs Related to the Narrowing of the Small Blood Vessels in the Lungs (START)

Pulmonary Arterial Hypertension

Argentina
Cairo University

Unknown

Adjuvant Radiotherapy Versus Observation After Radical Cystectomy in High Risk Urothelial Bladder Cancer

Urothelial Carcinoma Bladder | High-Risk Cancer

Egypt

Search clinical trials for: survival Risk

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Estonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations